[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Matcuk et al., 2015 - Google Patents

Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy

Matcuk et al., 2015

Document ID
1001629911088500471
Author
Matcuk G
Patel D
Schein A
White E
Menendez L
Publication year
Publication venue
Skeletal radiology

External Links

Snippet

We report a case of rapid recurrence of a giant cell tumor (GCT) of the distal radius in a 24- year-old woman following the cessation of long-term denosumab therapy. GCT of bone is a histologically benign tumor with multinucleated giant cells on a background of mononuclear …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/40—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4064—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment with arrangements for generating radiation specially adapted for radiation diagnosis adapted for producing a particular type of beam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/032—Transmission computed tomography [CT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Matcuk et al. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy
Dubory et al. Interest of denosumab for the treatment of giant-cells tumors and aneurysmal bone cysts of the spine. About nine cases
Macedo et al. Bone metastases: an overview
Zileli et al. Aneurysmal bone cysts of the spine
Müller et al. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone—a case series
Rutkowski et al. Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone
Takahashi et al. Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
Lange et al. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts
Federman et al. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets
Schachar An Update on the Nonoperative Treatment of Patients with Metastastic Bone Disease.
McCarthy et al. Giant cell tumour of the distal radius/ulna: response to pre-operative treatment with short-term denosumab
Liu et al. Hemicortical resection and reconstruction using pasteurised autograft for parosteal osteosarcoma of the distal femur
Yayan Denosumab for effective tumor size reduction in patients with giant cell tumors of the bone: a systematic review and meta-analysis
Sydlik et al. Hypercalcaemia after treatment with denosumab in children: bisphosphonates as an option for therapy and prevention?
Woon et al. Aneurysmal bone cyst treated with percutaneous doxycycline: is a single treatment sufficient?
Zuo et al. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case–control study
Huang et al. Eosinophilic granuloma of spine in adults: a report of 30 cases and outcome
Von Borstel et al. Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery
Jiang et al. Langerhans cell histiocytosis with multiple spinal involvement
Tahir et al. Malignant giant cell tumour of bone: a review of clinical, pathological and imaging features
Pappas et al. An intraosseous lipoma of the calcaneus: a case report
Nakazawa et al. Remarkable regression of a giant cell tumor of the cervical spine treated conservatively with denosumab: a case report
İltar et al. A case of an aneurysmal bone cyst of a metatarsal: review of the differential diagnosis and treatment options
Tabouret et al. Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis
Krygier et al. Operative management of metastatic melanoma in bone may require en bloc resection of disease